항카텝신 B 시장 : 제품 유형별, 용도별, 방법론별, 최종 사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)
Anti Cathepsin B Market, By Product Type, By Application, By Technique, By End User and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
상품코드
:
1350273
리서치사
:
Coherent Market Insights
발행일
:
2023년 08월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 항카텝신 B 시장은 2023년 1억 8,700만 달러에 달할 것으로 추정 및 예측되며, 예측 기간(2023-2030년) 동안 3.2%의 CAGR을 나타낼 것으로 예상됩니다.
| 보고 대상 범위 |
보고서 상세 |
| 기준년도 |
2022 |
2023년 시장 규모 |
1억 8,700만 달러 |
| 과거 데이터 |
2018년부터 2021년까지 |
예측 기간 |
2023-2030 |
| 예측 기간(2023-2030년)의 CAGR: |
3.20% |
2030년 가치 예측 |
2억 3,370만 달러 |
카텝신 B는 주로 정상 세포의 리소좀에 존재하는 시스테인 프로테아제이지만, 많은 형질전환된 세포의 세포막에 분비되거나 관련되어 있습니다. 카텝신 B는 모든 동물과 다른 생물체에 존재하며 세포의 단백질 대사에 중요한 역할을 합니다. 카텝신 계열에는 세린 프로테아제, 아스파르트산 프로테아제, 시스테인 프로테아제가 포함됩니다. 아스파르트 프로테아제 계열은 카테킨 D와 E, 시스테인 프로테아제 계열은 카테킨 B, L, H, H, K, S, O로 구성됩니다. 현재 승인된 카텝신 억제제는 시판되고 있지 않지만, 암, 외상성 뇌손상, 에볼라 감염 등 다양한 질병을 치료하기 위해 새로운 카텝신 억제제를 개발하기 위한 연구가 진행 중입니다. 항카텝신 B 항체는 주로 암, 외상성 뇌손상, 에볼라 출혈열 감염, 불임 등의 질병 치료에 사용되며, 현재 SARS-CoV-2의 치료제로 연구되고 있습니다. 카텝신 B는 세포외 매트릭스의 리모델링에 기여하는 프로테아제이며, 이를 통해 상처 치유 시 각질세포의 이동을 촉진하는 역할을 합니다.
시장 역학
주요 시장 진입자들의 치료, 합병 및 인수합병이 증가함에 따라 세계 항카텝신 B 시장의 성장이 촉진될 것으로 예상됩니다. 예를 들어, 2020년 3월 31일, National Center for Biotechnology Information은 카텝신 B(CTSB)가 엔드리소좀 구획과 세포 외 영역 모두에서 기능하는 풍부한 시스테인 프로테아제라고 설명하는 기사를 발표했습니다. 발표했습니다. 많은 전임상 및 임상 연구에서 CTSB가 많은 인간 질병에 관여하고 있으며, CTSB의 발현 수준 및 활성은 질병의 진행 및 중증도와 유의미한 상관관계가 있음을 보여주었습니다. 현재의 CTSB 억제제는 충분한 특이성과 약리활성이 부족합니다. 연구진은 구조에 기반한 합리적인 설계를 통해 인간 CTSB를 표적으로 하는 인간화 항체 억제제를 개발 및 제조했습니다.
본 조사의 주요 특징
- 이 보고서는 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 복합 연간 성장률(CAGR%)을 제공하는 세계 항카텝신 B 시장을 상세하게 분석합니다.
- 또한 다양한 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
- 세계 항카텝신 B 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과 및 전략과 같은 매개 변수를 기반으로 프로파일을 작성합니다.
- 조사 대상 주요 기업으로는 Merck KGaA, Bio-Techne, BioVision Inc. Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc. 등이 있습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 항카텝신 B 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 항카텝신 B 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 상황 개요
- 보고서 개요
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 최근 제품 출시
- 역학
- 합병, 인수, 제휴
- 규제 시나리오
- 주요 발전
- PEST 분석
제4장 세계의 항카텝신 B 시장 : COVID-19의 영향 분석
- 경제적 영향
- COVID-19 역학
- 수급에 대한 영향
제5장 세계의 항카텝신 B 시장 : 제품 유형별, 2018-2030년
제6장 세계의 항카텝신 B 시장 : 용도별, 2018-2030년
- 암
- 외상성 뇌손상
- 에볼라 출혈열 감염
- 불임 치료
- 기타
제7장 세계의 항카텝신 B 시장 : 방법별, 2018-2030년
- 면역조직화학
- 면역 형광법
- 웨스탄브롯팅
- ELISA법
- 유세포분석기
- 기타
제8장 세계의 항카텝신 B 시장 : 최종사용자별, 2018-2030년
제9장 세계의 항카텝신 B 시장 : 지역별, 2018-2030년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙아프리카
- 남아프리카
제10장 경쟁 구도
- Merck KGaA
- Bio-Techne
- BioVision Inc
- Santa Cruz Biotechnology, Inc
- MedChemExpress
- BioCat GmbH
- ApexBio Technology
- Cayman Chemical
- Selleck Chemicals
- BOC Sciences
- AG Scientific
- Virobay Inc
- Abcam Plc
제11장 섹션
LSH
영문 목차
The Global Anti-Cathepsin B Market is estimated to be valued at US$ 187.0 Million in 2023 and is expected to exhibit a CAGR of 3.2% during the forecast period (2023-2030).
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 187.0 Mn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
3.20% |
2030 Value Projection: |
US$ 233.7 Mn |
Cathepsin B is a cysteine protease found mainly in the lysosomes of normal cells but is secreted or associated with the plasma membrane of many transformed cells. It is found in all animals and other organisms and plays a key role in cellular protein metabolism. The cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class consists of cathepsins D and E. The cysteine protease class consists of cathepsins B, L, H, K, S, and O. Currently, there are no approved cathepsin inhibitors on the market, but research is ongoing to develop new cathepsin inhibitors for the treatment of various diseases such as cancer, traumatic brain injury, Ebola infection, and others. Anti-Cathespin B antibodies are majorly used for the treatment of disease conditions such as cancer, traumatic brain injury, Ebola infection, and fertility problems, and are currently under research for the treatment of SARS-CoV-2. Cathepsin B is a protease that contributes to the remodeling of the extracellular matrix and thereby promotes keratinocyte migration during wound healing.
Market Dynamics
Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global anti-cathepsin B market growth. For instance, on March 31, 2020, National Center for Biotechnology Information published an article explaining Cathepsin B (CTSB) is an abundant cysteine protease that functions in both endolysosomal compartments and extracellular regions. Many preclinical and clinical studies indicate that CTSB is involved in many human diseases. CTSB expression levels and activity are significantly correlated with disease progression and severity. Current CTSB inhibitors lack sufficient specificity and pharmacological activity. Using structure-based rational design, researchers developed and produced a humanized antibody inhibitor targeting human CTSB.
Key features of the study:
- This report provides an in-depth analysis of the global anti-cathepsin B market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global anti-cathepsin B market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global anti-cathepsin B market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-cathepsin B market.
Detailed Segmentation:
- Global Anti-Cathepsin B Market, By Product Type :
- Primary Antibodies
- Proteins and Peptides
- Lysates
- Global Anti-Cathepsin B Market, By Application :
- Cancer
- Traumatic Brain Injury
- Ebola Infection
- Fertility Treatment
- Others
- Global Anti-Cathepsin B Market, By Technique :
- Immunohistochemistry
- Immunofluorescence
- Western Blotting
- ELISA
- Flow Cytometry
- Others
- Global Anti-Cathepsin B Market, By End User
- Pharmaceutical Companies
- Academic and Research Institutes
- Global Anti-Cathepsin B Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Merck KGaA
- Bio-Techne
- BioVision Inc.
- Santa Cruz Biotechnology, Inc.
- MedChemExpress
- BioCat GmbH
- ApexBio Technology
- Cayman Chemical
- Selleck Chemicals
- BOC Sciences
- AG Scientific
- Virobay Inc.
- Abcam Plc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Technique
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Anti-Cathepsin B Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Anti-Cathepsin B Market, By Product Type, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Primary Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Proteins and Peptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Lysates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
6. Global Anti-Cathepsin B Market, By Application, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Traumatic Brain Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Ebola Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Fertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
7. Global Anti-Cathepsin B Market, By Technique, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Immunohistochemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Immunofluorescence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Western Blotting
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- ELISA
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Flow Cytometry
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Others
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
8. Global Anti-Cathepsin B Market, By End User, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Pharmaceutical Companies
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Academic and Research Institutes
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
9. Global Anti-Cathepsin B Market, By Region, 2018-2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Techne
- BioVision Inc
- Santa Cruz Biotechnology, Inc
- MedChemExpress
- BioCat GmbH
- ApexBio Technology
- Cayman Chemical
- Selleck Chemicals
- BOC Sciences
- AG Scientific
- Virobay Inc
- Abcam Plc
11. Section
- Research Methodology
- About Us
